Patents by Inventor Bryan A. Clark

Bryan A. Clark has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250228670
    Abstract: A delivery catheter as disclosed herein may be configured in various embodiments to minimize the potential for entanglement between cardiac repair components such as between sutures and coupled anchors. In various embodiments this is achieved by separating an anchor translation channel from a suture translation channel while maintaining the coupling between the anchor and the suture.
    Type: Application
    Filed: April 3, 2025
    Publication date: July 17, 2025
    Applicant: Boston Scientific Scimed, Inc.
    Inventors: Bryan A. Clark, Aiden Flanagan, Sean O'Sullivan, Fergal Horgan
  • Patent number: 12245891
    Abstract: Embodiments of the present disclosure relate to imaging a body part using sounds. In embodiments, a system comprises a motion sensor and a processing device communicatively coupled to the motion sensor. The motion sensor is configured to sense an acceleration wave produced by a sound emitted by a source and generate acceleration measurements in response to sensing the acceleration wave, wherein the source is associated with the body part of a subject. The processing device is configured to receive the acceleration measurements and determine a location of the source using a location of the motion sensor and the acceleration measurements. In addition, the processing device is configured to image the body part of the subject using the determined location of the source and the acceleration measurements.
    Type: Grant
    Filed: January 3, 2019
    Date of Patent: March 11, 2025
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Jonathan B. Shute, Pramodsingh H. Thakur, Bin Mi, Bryan A. Clark, Qi An, Ramesh Wariar, Krzysztof Z. Siejko
  • Patent number: 12089899
    Abstract: A virtual or augmented reality system is disclosed which is capable of both (i) evaluating prospective implantable neurostimulator patient candidates, and (ii) determining optimal stimulation settings for already-implanted neurostimulation patients. Physiological sensors are included with the system to provide objective measurements relevant to a patient's symptoms, such as pain in a Spinal Cord Stimulation (SCS) system. Such objective measurements are determined during the presentation of various virtual or augmented environments, and can be useful to determining which patients are suitable candidates to consider for implantation. Stimulation settings for already-implanted patients may be adjusted while presenting a virtual or augmented environment to the patient, with objective measurements being determined for each stimulation setting. Such objective measurements can then be used to determine optimal stimulation settings for the patient.
    Type: Grant
    Filed: December 20, 2022
    Date of Patent: September 17, 2024
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Elizabeth M. Annoni, Bryan A. Clark, Dennis Zottola, Kyle H. Srivastava, Jonathan B. Shute
  • Publication number: 20240261099
    Abstract: An implant system and method of delivery includes a catheter system including a sling catheter having a plurality of distal openings and a delivery catheter, disposed within the sling catheter and having a distal port. Suture coupled anchors may be sequentially delivered by the delivery catheter to a cardiac treatment site by aligning the port of the delivery catheter with different openings of the sling catheter and pushing the anchor through the port and the sling catheter to embed the anchor into cardiac tissue such as tissue of a papillary muscle. Each anchor may have a linear configuration for translation within the delivery catheter and a biased configuration that inhibits its reentry into the sling catheter once deployed. Once all anchors are deployed, the suture may be tightened, the anchored portion of the sling catheter may be detached, and the catheter system withdrawn.
    Type: Application
    Filed: April 18, 2024
    Publication date: August 8, 2024
    Applicant: Boston Scientific Scimed, Inc.
    Inventors: Dongming Hou, Raffaele Cicerone, Bryan A. Clark, Aiden Flanagan, Tim O'Connor
  • Patent number: 11992405
    Abstract: An implant system and method of delivery includes a catheter system including a sling catheter having a plurality of distal openings and a delivery catheter, disposed within the sling catheter and having a distal port. Suture coupled anchors may be sequentially delivered by the delivery catheter to a cardiac treatment site by aligning the port of the delivery catheter with different openings of the sling catheter and pushing the anchor through the port and the sling catheter to embed the anchor into cardiac tissue such as tissue of a papillary muscle. Each anchor may have a linear configuration for translation within the delivery catheter and a biased configuration that inhibits its reentry into the sling catheter once deployed. Once all anchors are deployed, the suture may be tightened, the anchored portion of the sling catheter may be detached, and the catheter system withdrawn.
    Type: Grant
    Filed: December 1, 2020
    Date of Patent: May 28, 2024
    Assignee: BOSTON SCIENTIFIC SCIMED, INC.
    Inventors: Dongming Hou, Raffaele Cicerone, Bryan A. Clark, Aiden Flanagan, Tim O'Connor
  • Publication number: 20230121855
    Abstract: A virtual or augmented reality system is disclosed which is capable of both (i) evaluating prospective implantable neurostimulator patient candidates, and (ii) determining optimal stimulation settings for already-implanted neurostimulation patients. Physiological sensors are included with the system to provide objective measurements relevant to a patient's symptoms, such as pain in a Spinal Cord Stimulation (SCS) system. Such objective measurements are determined during the presentation of various virtual or augmented environments, and can be useful to determining which patients are suitable candidates to consider for implantation. Stimulation settings for already-implanted patients may be adjusted while presenting a virtual or augmented environment to the patient, with objective measurements being determined for each stimulation setting. Such objective measurements can then be used to determine optimal stimulation settings for the patient.
    Type: Application
    Filed: December 20, 2022
    Publication date: April 20, 2023
    Inventors: Elizabeth M. Annoni, Bryan A. Clark, Dennis Zottola, Kyle H. Srivastava, Jonathan B. Shute
  • Patent number: 11559355
    Abstract: A virtual or augmented reality system is disclosed which is capable of both (i) evaluating prospective implantable neurostimulator patient candidates, and (ii) determining optimal stimulation settings for already-implanted neurostimulation patients. Physiological sensors are included with the system to provide objective measurements relevant to a patient's symptoms, such as pain in a Spinal Cord Stimulation (SCS) system. Such objective measurements are determined during the presentation of various virtual or augmented environments, and can be useful to determining which patients are suitable candidates to consider for implantation. Stimulation settings for already-implanted patients may be adjusted while presenting a virtual or augmented environment to the patient, with objective measurements being determined for each stimulation setting. Such objective measurements can then be used to determine optimal stimulation settings for the patient.
    Type: Grant
    Filed: June 17, 2019
    Date of Patent: January 24, 2023
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Elizabeth M. Annoni, Bryan A. Clark, Dennis Zottola, Kyle H. Srivastava, Jonathan B. Shute
  • Patent number: 11147967
    Abstract: Various aspects of the present disclosure are directed toward apparatuses, systems, and methods for delivering therapy to an adrenal gland of a patient. The apparatuses, systems, and methods may include a plurality of stimulation elements arranged configured to deliver stimulation energy through at least one of the plurality of stimulation elements to modulate aldosterone levels within the patient.
    Type: Grant
    Filed: October 18, 2018
    Date of Patent: October 19, 2021
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Lynne E Swanson, Barbara Huibregtse, Bryan A. Clark, Dennis B. Werner, Natalie A. Brill, Michael X. Govea, Umang Anand, William C. Stoffregen
  • Publication number: 20210161667
    Abstract: An implant system and method of delivery includes a catheter system including a sling catheter having a plurality of distal openings and a delivery catheter, disposed within the sling catheter and having a distal port. Suture coupled anchors may be sequentially delivered by the delivery catheter to a cardiac treatment site by aligning the port of the delivery catheter with different openings of the sling catheter and pushing the anchor through the port and the sling catheter to embed the anchor into cardiac tissue such as tissue of a papillary muscle. Each anchor may have a linear configuration for translation within the delivery catheter and a biased configuration that inhibits its reentry into the sling catheter once deployed. Once all anchors are deployed, the suture may be tightened, the anchored portion of the sling catheter may be detached, and the catheter system withdrawn.
    Type: Application
    Filed: December 1, 2020
    Publication date: June 3, 2021
    Inventors: Dongming Hou, Raffaele Cicerone, Bryan A. Clark, Aiden Flanagan, Tim O'Connor
  • Publication number: 20210154014
    Abstract: A system for transluminal delivery of cardiac repair components into a heart includes a visualization catheter having an imaging device disposed at a distal end. An anchor lumen extends through the visualization catheter to an anchor port disposed on its distal wall. An adjustment mechanism is translatably disposed within the visualization catheter and configured to adjust a height of the anchor port relative to a septum of the heart. The imaging device may be used to visualize the placement of anchors expelled from the port into a tissue target. The adjustment mechanism enables accurate placement of multiple anchors along a consistent axis within the heart by rotating the visualization catheter to align the port with different tissue targets. The anchors may be coupled to sutures and the tissue targets may include papillary muscles that are reconfigured by pulling together and securing the sutures to approximate a healthy papillary structure.
    Type: Application
    Filed: November 19, 2020
    Publication date: May 27, 2021
    Inventors: Dongming Hou, Raffaele Cicerone, Bryan A. Clark, Aiden Flanagan, Tim O'Connor
  • Publication number: 20210059820
    Abstract: A delivery catheter as disclosed herein may be configured in various embodiments to minimize the potential for entanglement between cardiac repair components such as between sutures and coupled anchors. In various embodiments this is achieved by separating an anchor translation channel from a suture translation channel while maintaining the coupling between the anchor and the suture.
    Type: Application
    Filed: August 27, 2020
    Publication date: March 4, 2021
    Inventors: Bryan A. Clark, Aiden Flanagan, Sean O'Sullivan, Fergal Horgan
  • Patent number: 10583286
    Abstract: Aspects of the present disclosure are directed toward apparatuses, systems, and methods for delivering therapy to an adrenal gland of a patient. The apparatuses, systems, and methods may include a housing and a plurality of electrodes arranged with the housing. In addition, one or more of the plurality of electrodes may deliver stimulation energy to modulate L-dopa release.
    Type: Grant
    Filed: December 19, 2017
    Date of Patent: March 10, 2020
    Assignee: BOSTON SCIENTIFIC NEUROMODULATION CORPORATION
    Inventors: Lynne E. Swanson, William C. Stoffregen, Bryan A. Clark, Michael X. Govea, Dennis B. Werner, Natalie A. Brill, Pramodsingh H. Thakur
  • Publication number: 20200030035
    Abstract: A virtual or augmented reality system is disclosed which is capable of both (i) evaluating prospective implantable neurostimulator patient candidates, and (ii) determining optimal stimulation settings for already-implanted neurostimulation patients. Physiological sensors are included with the system to provide objective measurements relevant to a patient's symptoms, such as pain in a Spinal Cord Stimulation (SCS) system. Such objective measurements are determined during the presentation of various virtual or augmented environments, and can be useful to determining which patients are suitable candidates to consider for implantation. Stimulation settings for already-implanted patients may be adjusted while presenting a virtual or augmented environment to the patient, with objective measurements being determined for each stimulation setting. Such objective measurements can then be used to determine optimal stimulation settings for the patient.
    Type: Application
    Filed: June 17, 2019
    Publication date: January 30, 2020
    Inventors: Elizabeth M. Annoni, Bryan A. Clark, Dennis Zottola, Kyle H. Srivastava, Jonathan B. Shute
  • Patent number: 10478613
    Abstract: A temporary implantable medical device lead includes a connector, a helically coiled conductor and a first mechanical element. The connector is configured to connect the lead to an external control module. The helically coiled conductor has a proximal end mechanically and electrically connected to the connector. The conductor includes a plurality of filars mechanically and electrically connected to the connector. The first mechanical element includes a metal tube having a plurality of longitudinally spaced grooves formed along an exterior of the tube. The plurality of longitudinally spaced grooves receives at least some of the plurality of filars. The at least some of the plurality of filars electrically connected to the first mechanical element such that the first mechanical element is configured as an electrode to deliver electrical stimulation to portions or systems of a body from the external control module.
    Type: Grant
    Filed: December 6, 2016
    Date of Patent: November 19, 2019
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Bryan A. Clark, Timothy R. Jackson, Benjamin J. Haasl
  • Patent number: 10441788
    Abstract: Aspects of the present disclosure are directed toward apparatuses, systems, and methods for delivering therapy to an adrenal gland of a patient. The apparatuses, systems, and methods may include a lead body that attaches to a portion of the adrenal gland of the patient; and a plurality of electrodes arranged along the lead body. In addition, one or more of the plurality of electrodes may deliver stimulation energy to modulate catecholamine release from chromaffin cells within the adrenal gland.
    Type: Grant
    Filed: August 22, 2017
    Date of Patent: October 15, 2019
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Lynne E. Swanson, William C. Stoffregen, Bryan A. Clark, Michael X. Govea, Dennis B. Werner, Natalie A. Brill, Pramodsingh H. Thakur
  • Publication number: 20190254740
    Abstract: Devices, systems, and methods for regulating glucose levels, including treating diabetes, in accordance with the present disclosure may include a catheter having an expandable or inflatable portion, one or more electrodes disposed on the expandable or inflatable portion of the catheter, wherein the electrodes are configured to deliver energy to a patient's gastrointestinal tract, and a drug delivery mechanism for delivering a drug therapy subsequent to energy delivery by the electrodes. A method for regulating glucose levels according to the present disclosure may include inserting a catheter into a patient's gastrointestinal tract, positioning the catheter in a duodenum of the patient's gastrointestinal tract, expanding or inflating a portion of the catheter in the duodenum, the expandable or inflatable portion of the catheter including electrodes, applying energy to the duodenum via the electrodes to ablate tissue of the duodenum, and delivering a drug therapy to the ablated tissue of the duodenum.
    Type: Application
    Filed: February 19, 2019
    Publication date: August 22, 2019
    Inventors: Vijay Koya, Elizabeth M. Annoni, Bryan A. Clark, Bruce Forsyth, Hong Cao, Matthew R. DeWitt, Kyle H. Srivastava
  • Publication number: 20190111253
    Abstract: Various aspects of the present disclosure are directed toward apparatuses, systems, and methods for delivering therapy to an adrenal gland of a patient. The apparatuses, systems, and methods may include a plurality of stimulation elements arranged configured to deliver stimulation energy through at least one of the plurality of stimulation elements to modulate aldosterone levels within the patient.
    Type: Application
    Filed: October 18, 2018
    Publication date: April 18, 2019
    Inventors: Lynne E Swanson, Barbara Huibregtse, Bryan A. Clark, Dennis B. Werner, Natalie A. Brill, Michael X. Govea, Umang Anand, William C. Stoffregen
  • Publication number: 20180368765
    Abstract: The present disclosure relates generally to systems and methods for detecting and monitoring the exercise pressor reflex. In some embodiments, a medical system includes a first sensor connected to a user, wherein the first sensor detects an exertion metric of the user, and a second sensor connected to the user, wherein the second sensor detects a blood pressure metric of the user. The medical system may further include a processing component in communication with the first and second sensors, wherein the processing component is capable of processing the exertion metric and the blood pressure metric to determine an elevated blood pressure metric of the user based on a comparison between a baseline blood pressure metric and the detected blood pressure metric. The processing component may further determine an exercise pressor reflex (EPR) metric based on a comparison between the elevated blood pressure metric and the exertion metric.
    Type: Application
    Filed: June 26, 2018
    Publication date: December 27, 2018
    Inventors: Kyle H. Srivastava, Craig M. Stolen, Bryan A. Clark, Pramodsingh H. Thakur
  • Patent number: 10039918
    Abstract: An implantable lead includes a lead body having a proximal end portion and a distal end portion. The lead body includes an insulative member having a lumen extending longitudinally between the proximal end portion and the distal end portion. The lead body also includes a generally tubular helical liner disposed coaxially with the lumen within the insulative member. A pitch of the helical liner varies along the length of the lead. The implantable lead also includes an electrode disposed along the lead body in the distal end portion thereof, and a conductor disposed within the lumen and electrically coupled to the electrode. A terminal connector is coupled to the proximal end portion of the lead body and to the conductor.
    Type: Grant
    Filed: April 25, 2016
    Date of Patent: August 7, 2018
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Arthur J. Foster, Daniel J. Foster, Christopher R. Perrey, Andrew L. De Kock, Patrick Willoughby, Bryan A. Clark
  • Publication number: 20180104480
    Abstract: Aspects of the present disclosure are directed toward apparatuses, systems, and methods for delivering therapy to an adrenal gland of a patient. The apparatuses, systems, and methods may include a housing and a plurality of electrodes arranged with the housing. In addition, one or more of the plurality of electrodes may deliver stimulation energy to modulate L-dopa release.
    Type: Application
    Filed: December 19, 2017
    Publication date: April 19, 2018
    Inventors: Lynne E. Swanson, William C. Stoffregen, Bryan A. Clark, Michael X. Govea, Dennis B. Werner, Natalie A. Brill, Pramodsingh H. Thakur